Riskpilot← Back to searchSign inGet full accessRM Medical Oy
OYActiveY-tunnus 2267591-4Dagmarinkatu 5-B12Medical specialists activities · NACE 8622Est. 20091 employees
Revenue 2025
EUR 607K
+5% vs 2024
EBITDA margin
14.3%
-54% vs 2024
Equity ratio
88.6%
Financial strength
Net profit 2025
EUR 63K
-57% vs 2024
| Revenue | EUR 607K | +5% |
| EBITDA | EUR 87K | -54% |
| Net profit | EUR 63K | -57% |
| Total assets | EUR 1,2M | -2% |
| Equity | EUR 1M | -2% |
| Employees | 1 | — |
Legal name
RM Medical Oy
Y-tunnus number
2267591-4
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
18. toukokuuta 2009
Share capital
EUR 2 500
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-10-31
Financial year
January – December
Company purpose
Yhtiön toimiala on terveydenhuoltopalvelut. Yhtiö voi harjoittaa välitystä ja kauppaa, sijoitustoimintaa, koulutusta ja konsultointia. Yhtiö voi myös harjoittaa koti- ja ulkomaisten kiinteistöjen, asunto-, kiinteistö- ja lomaosakkeiden, osuuksien ja oikeuksien omistamista, hallinnointia, ostoa, myyntiä ja vuokrausta.
Address
Dagmarinkatu 5-B12
Phone
+3580405144042
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 461 | 590 | 560 | 577 | 607 |
| Staff expenses | −1 | −29 | −85 | −214 | −290 |
| EBITDA | 318 | 355 | 301 | 190 | 87 |
| Depreciation & amort. | −1 | −2 | −1 | −1 | −1 |
| EBIT | 317 | 353 | 300 | 280 | 86 |
| Net financials | −3 | −4 | −4 | −3 | −2 |
| Profit before tax | 314 | 349 | 296 | 186 | 84 |
| Tax | 63 | 69 | 61 | 38 | 20 |
| Net profit | 251 | 280 | 235 | 147 | 63 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 947 | 1 056 | 1 158 | 1 193 | 1 171 |
| Equity | 590 | 822 | 992 | 1 060 | 1 038 |
| Long-term debt | 283 | 180 | 137 | 94 | 68 |
| Short-term debt | 74 | 53 | 30 | 39 | 65 |
| Total debt | 357 | 233 | 167 | 134 | 133 |
EBITDA margin
14.3%
This company
15.8%
Market median
-9% vs market
20212025
Equity ratio
88.6%
This company
38.2%
Market median
+132% vs market
20212025
Return on equity
6.1%
This company
18.4%
Market median
-67% vs market
20212025
Net profit margin
10.5%
This company
8.1%
Market median
+30% vs market
20212025
Asset turnover
0.52×
This company
1.12×
Market median
-54% vs market
20212025
Debt / equity
0.13×
This company
0.62×
Market median
+79% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2024-11-01 – 2025-10-31
- Annual report 2024Filed via PRH / YTJ · Period 2023-11-01 – 2024-10-31
- Annual report 2023Filed via PRH / YTJ · Period 2022-11-01 – 2023-10-31
- Annual report 2022Filed via PRH / YTJ · Period 2021-11-01 – 2022-10-31
- Annual report 2021Filed via PRH / YTJ · Period 2020-11-01 – 2021-10-31
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
MM Deputy Member | Deputy Member | 2009 |
RM Chief Executive Officer | Chief Executive Officer | 2009 |
AK Audit | Audit | 2024 |
JA Deputy auditor | Deputy auditor | 2024 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of RM Medical Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Marina Madanat | Deputy Member | 0 companies |
| Rami Madanat | Chief Executive Officer | 0 companies |
| Ari-Matti Korkeamäki | Audit | 0 companies |
| Jose Adam Juhani Kautonen | Deputy auditor | 0 companies |